These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3989833)

  • 21. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of turinal in the treatment of habitual abortion].
    Alimova KhR
    Akush Ginekol (Mosk); 1982 Jan; (1):55-6. PubMed ID: 7065370
    [No Abstract]   [Full Text] [Related]  

  • 23. Semilobar holoprosencephaly in a 12-month-old baby boy born to a primigravida patient with type 1 diabetes mellitus: a case report.
    Pallangyo P; Lyimo F; Nicholaus P; Makungu H; Mtolera M; Mawenya I
    J Med Case Rep; 2016 Dec; 10(1):358. PubMed ID: 27998308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progestagens in threatened abortion.
    Tognoni G; Ferrario L; Inzalaco M; Crosignani PG
    Lancet; 1980 Dec; 2(8206):1242-3. PubMed ID: 6108408
    [No Abstract]   [Full Text] [Related]  

  • 25. Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.
    Queisser-Luft A
    Early Hum Dev; 2009 Jun; 85(6):375-7. PubMed ID: 19193503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of threatened and habitual abortions with Turinal preparations].
    Szucka-May H; Sternadel Z
    Ginekol Pol; 1975 Dec; 46(12):1265-9. PubMed ID: 1205224
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of turinal in the combined treatment of threatened abortion and its effect on placental hormone function].
    Kosheleva NG; Svechnikova FA; Golumb SB
    Akush Ginekol (Mosk); 1981 May; (5):23-5. PubMed ID: 7306358
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dydrogesterone (Duphaston) in the prevention of risk of ultrasound guided amniocentesis].
    Korczyński J
    Ginekol Pol; 2000 Aug; 71(8):709-13. PubMed ID: 11082907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dydrogesterone has no effect on uterine fibroids when used to prevent miscarriage in pregnant women with uterine fibroids.
    Wang S; Wang XT; Liu RH; Liu M; Wu YR; Huang XY; Zhao N; Mu YL
    Ginekol Pol; 2017; 88(12):679-685. PubMed ID: 29303226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Diethylstilbestrol Legacy: A Powerful Case Against Intervention in Uncomplicated Pregnancy.
    Troisi R; Hatch EE; Titus L
    Pediatrics; 2016 Nov; 138(Suppl 1):S42-S44. PubMed ID: 27940976
    [No Abstract]   [Full Text] [Related]  

  • 32. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possible teratogenic effects of drugs administered to pregnant women].
    Acciaro E; Acciaro L; La Scala G; Giuseppini S; Valentini A
    Clin Ter; 1988 Mar; 124(5):369-71. PubMed ID: 2974347
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug noxae as indications for pregnancy interruption].
    Neubert D
    Internist (Berl); 1978 May; 19(5):304-9. PubMed ID: 350801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of selected progestational hormones used for the protection of high-risk pregnancy on the clinical course, morphological changes and proliferative activity of the trophoblast].
    Papierowski Z
    Ginekol Pol; 1981 Mar; 52(3):298-303. PubMed ID: 7262593
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of prolonged use of progesterone compounds on fetal weight].
    Hertz P; Sani L
    Akush Ginekol (Mosk); 1980 Aug; (8):24-5. PubMed ID: 7416389
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilateral porencephalic defect in a newborn after injection of benzol during pregnancy.
    Bordarier C; Robain O; Ponsot G
    Brain Dev; 1991; 13(2):126-9. PubMed ID: 1892217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical effect of allylestrenol on benign prostatic hypertrophy].
    Tajima A; Aso Y; Ushiyama T; Hata M; Kambayashi T; Ohmi Y; Masuda H; Nakahara M; Kitagawa M; Suzuki A
    Hinyokika Kiyo; 1986 Mar; 32(3):477-85. PubMed ID: 2425610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of allylestrenol on hpl serum levels in high-risk pregnancies (author's transl)].
    Spona J; Müller-Tyl E; Leodolter S
    Z Geburtshilfe Perinatol; 1976 Oct; 180(5):356-62. PubMed ID: 969796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined effects of embryotoxic and teratogenic environmental chemical factors (review of the literature)].
    Litvinov NN; Kazachkov VI; Astakhova LF; Gasimova ZM
    Gig Sanit; 1990 Nov; (11):80-2. PubMed ID: 2093602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.